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Case report 
A 45 year-old man with recent adult-onset seizure disor-
der presented to the emergency department with altered 
mental status after a witnessed, generalized, tonic-clonic 
seizure. For one month, he had a history of  waxing and 
waning aphasia, word-finding difficulty, and right-lower-
extremity paresis. Six years before, he had experienced his 
first and only previous seizure. Following the cardinal sei-
zure, his outpatient neurologist started him on leveti-
racetam for seizure prophylaxis and had imaging studies 
obtained (Fig. 1). 
Magnetic resonance imaging (MRI) on admission re-
vealed diffuse disease, worse within the left cerebral hemi-
sphere, predominantly superiorly in both frontal lobes and 
in the left temporal lobe, with associated edema with a left-
to-right midline shift of  approximately 7 mm, all appearing 
since an MRI scan six years earlier (Figs 1, 2). A right 
periventricular lesion likely represented a worsening of  a 
similar lesion that was present on prior imaging (Fig. 1). 
There were also multiple intra-axial, heterogeneously en-
hancing lesions in the bilateral cerebral hemispheres with 
surrounding vasogenic edema (Fig. 2). The largest lesion in 
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Figure 1. 45-year-old male with TMS. Initial imaging of pa-
tient, performed at first with new-onset seizure, demon-
strates a small periventricular hyperintense lesion (A), with 
marked worsening of periventricular lesions on imaging 
performed 6 years later (B) on conventional T2-weighted 
MRI images.
the left temporal lobe had a large fluid component corre-
sponding to an enlarged trapped left temporal horn, a very 
rare and atypical feature in TMS.
In additional to conventional brain MRI, diffusion tensor 
imaging (DTI) was also performed. DTI maps as well as 
conventional MRI scans demonstrated destruction, dis-
placement, and invasion of  adjacent cerebral parenchyma, 
white-matter tracts, and juxtacortical U-fibers, imaging 
features suggestive of  a demyelinating process (Figs. 3, 4). 
Measures to reduce intracranial pressure, including high-
dose corticosteroids, were at once initiated on hospital ad-
mission. During the course of  his hospital stay, the patient 
required intubation for central respiratory failure. A tem-
porary right external ventricular drain and a left ventricu-
loperitoneal shunt were placed for correction of  hydro-
cephalus, with brain biopsy obtained on neurosurgical in-
tervention. Histopathology of  the tissue revealed foam-cell 
macrophages and T-lymphocytes with reactive astrocytes, 
loss of  myelin, and preservation of  axons— findings consis-
tent with active demyelination (Fig. 5). The differential di-
agnosis by pathology at this point was  acute demyelinating 
encephalomyelitis (ADEM), post-infectious demyelination, 
and multiple sclerosis (MS) of  the tumefactive subtype.
Extensive cerebrospinal fluid analysis following lumbar 
puncture provided no evidence of  infectious etiology. It 
revealed an elevated IgG index without intrathecal IgG 
synthesis, and no oligoclonal bands. Further corroborative 
history later revealed that the patient had four years earlier 
been informed that he might have MS. High-dose steroids 
for presumed TMS were continued at this time.
Following treatment with steroids, the patient demon-
strated improving mentation and right hemiparesis, and 
restoration of  normal speech. The ventriculoperitoneal 
shunt was kept in place, and the patient was given the di-
agnosis of  TMS with atypical imaging features.
 
Discussion
MS is an immune-mediated demyelinating disease result-
ing in neurologic deficits. Unlike the typical clinical presen-
tation of  MS, which is generally more insidious, TMS first 
presents with focal neurological deficits, seizure, or aphasia 
and may even be attributed to an acute ischemic stroke in 
some cases (see summary table) (1). TMS is itself  an un-
usual presentation of  MS, some suggesting that the inci-
dence of  tumefactive brain lesions is only 2.8% in MS pa-
tients (2). Our case is biopsy-proven tumefactive MS with 
atypical features even for TMS, a rare imaging presenta-
tion. As in all MS, inflammation with loss of  myelination 
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Figure 2. 45-year-old male with TMS. MRI scans performed 
on this hospital admission of patient demonstrate a large 
area of periventricular edema and a trapped left lateral ven-
tricle on conventional T2-weighted MRI (A), with periven-
tricular enhancement on gadolinium-enhanced T1-weighted 
imaging (B).
Figure 3. 45-year-old male with TMS. Diffusion tensor imag-
ing (DTI) shows affected periventricular pathways and optic 
radiations in this case of TMS (A) as compared with a nor-
mal control (B) with a loss of color due to decreased neu-
ronal integrity in (A). The fractional anisotropy color legend 
(C) depicts fiber tract directions.
Figure 4. 45-year-old male with TMS. U-fibers are involved 
by demyelination in this case of TMS (A) but spared in a 
comparison case of ischemic small vessel disease (B) as 
seen on conventional T2-weighted MRI images.
seen on histological examination is a key diagnostic feature. 
MRI is the most sensitive noninvasive means of  detecting 
MS lesions and can characterize lesions suspicious for TMS 
as well, in many cases avoiding the need for biopsy. 
Classic MRI findings of  MS include bright, regular-
appearing, ovoid periventricular or subcortical white matter 
lesions on T2-weighted and FLAIR with or without con-
trast enhancement, reflective of  active demyelination. Also 
seen are “dark lesions” on T1-weighted imaging that por-
tend a worse prognosis and reflect neuronal cell death. Ex-
vacuo ventriculomegaly and diffuse white matter atrophy 
may also occur in this condition (3).
TMS, as opposed to typical MS, poses multiple diagnos-
tic challenges aside from imaging studies. Histochemical 
analysis for possible oligoclonal-band positivity in cerebro-
spinal fluid may not be present in tumefactive disease, as 
was the case in our patient (2). Unlike MS, which presents 
on imaging with multiple focal periventricular white-matter 
lesions, TMS often presents as large enhancing lesions, 
mimicking neoplasm, abscess, or stroke; clinical presenta-
tions parallel these conditions, thereby obfuscating the dif-
ferential diagnosis. The existence of  mass effect and edema 
surrounding a lesion greater than 2 cm does not help in 
excluding neoplasm or infection versus tumefactive demye-
linating lesions. Radiological-pathological correlations do, 
however, suggest that certain peculiar imaging appearances 
on MRI such as "open" or "broken" ring gadolinium en-
hancement (Fig. 6) suggest lesions with atypical demyelina-
tion (that is, TMS) rather than neoplasm or infection (4-6). 
Some other studies suggest that dilatation of  cerebral veins 
either in or around these tumefactive lesions may suggest 
this alternative diagnosis as well (5, 7). In cases where these 
hallmark imaging features (see summary table) are not pre-
sent and where clinical diagnosis is uncertain, brain biopsy 
may be used to narrow the differential diagnosis. Where 
brain biopsy is declined or not indicated, some authors 
have found that followup imaging may be used as a diag-
nostic aid to confirm the diagnosis, with interval improve-
ment of  these lesions following steroid therapy (8). Moreo-
ver, many cases of  TMS will go on to develop definite MS 
(70%), and most will have multiple lesions on followup im-
aging studies (83%), suggesting that looking for the charac-
teristic time-space phenomenon of  MS lesions may help 
avert brain biopsy (9).
On magnetic resonance spectroscopy, decreased N-
acetylaspartate (NAA) levels and other patterns proposed 
by some authors may aid in differentiation of  tumefactive 
demyelination from neoplasm, though there is much con-
troversy on this subject (see differential diagnosis table) (5, 
10, 11). However, demonstrating abnormal levels of  cho-
line, N-acetyl aspartate, glutamate-glutamine, and lactate 
by MR spectroscopy has been suggested to help differenti-
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Figure 5. 45-year-old male with TMS. Histochemical and 
immunohistochemical stains of this patient’s periventricular 
lesion (magnified 400x). (A) Romanovsky smear prepara-
tion showing predominance of foam cell macrophages; (B) 
Hematoxylin and eosin (H&E) stain shows a hypercellular 
macrophage-rich lesion; (C) Neurofilament protein stain 
shows persistence of axons (brown); (D) Luxol Fast Blue 
demonstrates myelin loss (LFB stains myelin blue).
Figure 6. 45-year-old male with TMS. MRI of this separate 
comparison case of TMS in an adult male patient is charac-
terized by more classic features, including a periventricular 
lesion on conventional T2-weighted MRI with edema and 
minimal midline shift (A), with an incomplete ring of en-
hancement on gadolinium-enhanced T1-weighted images 
(B).
ate tumefactive lesions of  MS (10). An elevated choline/
creatine ratio, increased lactate, and normal N-
acetylaspartate/creatine ratio may be regarded as sugges-
tive of  inflammation or demyelination (1). However, the 
role of  MRS in helping to clarify the diagnosis of  TMS is 
not yet definitely established.
In conclusion, we reviewed the imaging findings of  a 
biopsy-proven case of  TMS with atypical features. This 
case had the unusual feature of  an enlarged temporal horn 
that was likely due to ependymal adhesions. Multiple en-
hancing lesions in this setting suggest neoplasm, infection, 
or ischemia (12). However, in this case there was evidence 
of  periventricular disease, hinting at the diagnosis of  TMS 
despite the presence and configuration of  the atypical fea-
tures, which was confirmed with biopsy and verified by 
followup imaging demonstrating rapid resolution with ster-
oid therapy. 
A diagnosis of  TMS relies on the correlation of  clinical 
examination and history with the potential imaging findings 
of  a tumefactive lesion on MRI, such as an incomplete ring 
of  enhancement (Fig. 6). This case highlights the variable 
imaging presentation and atypical nature of  TMS that con-
tinues to challenge clinicians evaluating patients with atypi-
cal intracranial lesions and unusual clinical presentations. 
Differential table
Diagnosis MRI
TMS Acute lesions larger than 2 cm often associated 
with edema and open or "'broken ring" en-
hancement. Mass effect and a resulting shift 
across midline may also be present. 
Neoplasm Similar to TMS, but with complete ring en-
hancement; mass effect is generally greater.
Abscess Similar to TMS, but with complete ring en-
hancement. Extensive edema compared to le-
sion size is often characteristic.




Etiology The cause of MS is unknown, but it is con-
sidered an autoimmune disease. Inflamma-
tion and demyelination are hallmark features 
of its pathogenesis. TMS is an uncommon 
presentation of MS. 
Incidence 0.1-2.8% of multiple sclerosis patients.
Gender ratio 1.2:1 female to male predominance
Age predilec-
tion
10% before age of 20 years, 70% between 20 
and 40, and 20% after age 40. Median age of 
onset is 37 years.
Treatment Glucocorticoids
Prognosis Relapsing, remitting MS is characterized by 
periods of neurological disability followed by 
periods of recovery. 85% of MS cases present 
with relapsing remitting MS; 50% of these 
will develop secondary progressive MS 
within 10 years, and 90% will within 25 
years. Secondary progressive MS involves 
increasing, permanent neurological damage. 
10% present with primary progressive MS, 
which involves a steady and permanent de-
cline in neurological function from the onset. 
5% present with progressive relapsing MS ,in 
which there is permanent neurological de-
cline, as well as acute MS attacks.
Findings on 
imaging
TMS is characterized by atypical features of 
MS such as lesions greater than 2 cm in di-
ameter, mass effect (71%), edema (100%), 
and ring enhancement with Gadolinium-
enhanced MRI (38-50%), usually open-ring 
(31%). Venous dilatations may be seen in or 
around these lesions.
References
1.	 Yacoub HA, Al-Qudahl ZA, Lee HJ, et al. Tumefac-
tive multiple sclerosis presenting as acute ischemic 
stroke. J Vasc Interv Neurol 2011;4:21-23 [PubMed]
2.	 Brant WE, Helms CA. Fundamentals of  diagnostic radiol-
ogy. Philadelphia: Lippincott, Williams & Wilkins; 
2007. 
3.	 Miron S, Tal S, Achiron A. Diffusion tensor imaging 
analysis of  tumefactive giant brain lesions in multiple 




4. 	 Altintas A, Petek B, Isik N, et al. Clinical and radio-
logical characteristics of  tumefactive demyelinating 
Neuroimaging of tumefactive multiple sclerosis with atypical features
RCR Radiology Case Reports | radiology.casereports.net! 4! 2012 | Volume 7 | Issue 4
lesions: follow-up study. Mult Scler 2012. Ahead of  
print, available at: 
http://msj.sagepub.com/content/early/2012/03/02/
1352458512438237.abstract [PubMed]
5. 	 Kiriyama T, Kataoka H, Taoka T, et al. Characteristic 
neuroimaging in patients with tumefactive demyelinat-
ing lesions exceeding 30 mm. J Neuroimaging 
2011;21:e69-77 [PubMed]
6. 	 Given CA, 2nd, Stevens BS, Lee C. The MRI appear-
ance of  tumefactive demyelinating lesions. AJR Am J 
Roentgenol 2004;182:195-199 [PubMed]
7. 	 Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-
enhanced T2*-weighted MR imaging of  tumefactive 
demyelinating lesions. AJNR Am J Neuroradiol 
2001;22:1109-1116 [PubMed]
8. 	 Kalanie H, Harandi AA, Bakhshandehpour R, Hei-
dari D. Multiple large tumefactive MS plaques in a 
young man: A diagnostic enigma and therapeutic chal-
lenge. Case Rep Radiol. 2012;363705. Available at: 
http://www.hindawi.com/crim/radiology/2012/3637
05/ [PubMed]
9. 	 Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical 
and radiographic spectrum of  pathologically con-
firmed tumefactive multiple sclerosis. Brain 
2008;131:1759-1775 [PubMed]
10. 	Kalis M, Bowen BC, Quencer RM. Metabolite find-
ings in tumefactive demyelinating lesions utilizing short 
echo time proton magnetic resonance spectroscopy. 
AJNR Am J Neuroradiol 2007;28:1427; author reply 
1427-1428 [PubMed]
11. 	Cianfoni A, Niku S, Imbesi SG. Metabolite findings in 
tumefactive demyelinating lesions utilizing short echo 
time proton magnetic resonance spectroscopy. AJNR 
Am J Neuroradiol 2007;28:272-277 [PubMed]
12. Javalkar V, Manix M, Wilson J, et al. Open ring en-
hancement in atypical brain demyelination. J Clin Neu-
rosci 2012;19:910-912 [PubMed]
Neuroimaging of tumefactive multiple sclerosis with atypical features
RCR Radiology Case Reports | radiology.casereports.net! 5! 2012 | Volume 7 | Issue 4
